These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7885448)

  • 1. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor.
    Bond RA; Leff P; Johnson TD; Milano CA; Rockman HA; McMinn TR; Apparsundaram S; Hyek MF; Kenakin TP; Allen LF
    Nature; 1995 Mar; 374(6519):272-6. PubMed ID: 7885448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2-adrenoceptor activation.
    Nagaraja S; Iyer S; Liu X; Eichberg J; Bond RA
    Br J Pharmacol; 1999 Jul; 127(5):1099-104. PubMed ID: 10455254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic infusion of beta-adrenoceptor antagonist and inverse agonists decreases elevated protein kinase A activity in transgenic mice with cardiac-specific overexpression of human beta 2-adrenoceptor.
    Liu X; Callaerts-Vegh Z; Evans KL; Bond RA
    J Cardiovasc Pharmacol; 2002 Sep; 40(3):448-55. PubMed ID: 12198331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inverse agonist: a novel discovery in receptor research].
    Zhang YY; Han QD
    Sheng Li Ke Xue Jin Zhan; 1997 Jan; 28(1):9-13. PubMed ID: 10921070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.
    Molenaar P; Chen L; Semmler AB; Parsonage WA; Kaumann AJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1020-8. PubMed ID: 17714089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.
    Hattori Y; Sakuma I; Nakao Y; Kanno M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1077-85. PubMed ID: 2888870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
    Marsh JD; Smith TW
    Mol Pharmacol; 1985 Jan; 27(1):10-8. PubMed ID: 2981398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of structural domains for G protein coupling and ligand binding in beta 3-adrenergic receptor.
    Guan XM; Amend A; Strader CD
    Mol Pharmacol; 1995 Sep; 48(3):492-8. PubMed ID: 7565630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An efficacy-dependent effect of cardiac overexpression of beta2-adrenoceptor on ligand affinity in transgenic mice.
    Gürdal H; Bond RA; Johnson MD; Friedman E; Onaran HO
    Mol Pharmacol; 1997 Aug; 52(2):187-94. PubMed ID: 9271340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
    Green SA; Holt BD; Liggett SB
    Mol Pharmacol; 1992 May; 41(5):889-93. PubMed ID: 1350321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of agonists and antagonists with beta-adrenergic receptors.
    Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
    Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective regulation of beta-1 and beta-2 adrenergic receptors by atypical agonists.
    Neve KA; Barrett DA; Molinoff PB
    J Pharmacol Exp Ther; 1985 Dec; 235(3):657-64. PubMed ID: 2867205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolving concepts of partial agonism. The beta-adrenergic receptor as a paradigm.
    Jasper JR; Insel PA
    Biochem Pharmacol; 1992 Jan; 43(2):119-30. PubMed ID: 1346741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta adrenoceptor interaction of full and partial agonists in the cat heart and soleus muscle.
    Hedberg A; Mattsson H
    J Pharmacol Exp Ther; 1981 Dec; 219(3):798-808. PubMed ID: 6117657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. I. High- and low-affinity states of agonist binding to membrane-bound beta adrenergic receptors.
    Contreras ML; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Apr; 237(1):154-64. PubMed ID: 2870174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse agonism at heptahelical receptors: concept, experimental approach and therapeutic potential.
    Daeffler L; Landry Y
    Fundam Clin Pharmacol; 2000; 14(2):73-87. PubMed ID: 10796054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac beta receptors--experimental aspects].
    Kaumann AJ
    Z Kardiol; 1983 Feb; 72(2):63-82. PubMed ID: 6133398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irreversible binding of the fluorescent beta-adrenoceptor probes alprenolol-NBD and pindolol-NBD to specific and non-specific binding sites.
    Rademaker B; Kramer K; Bast A; Timmerman H
    Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):147-59. PubMed ID: 2839876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J; Zhang LF; Han C; Yu GS; Ma J
    J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.